These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 33017575)

  • 1. N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.
    Xu Z; Peng B; Cai Y; Wu G; Huang J; Gao M; Guo G; Zeng S; Gong Z; Yan Y
    Biochem Pharmacol; 2020 Dec; 182():114258. PubMed ID: 33017575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of m6A RNA methylation in cancer.
    Sun T; Wu R; Ming L
    Biomed Pharmacother; 2019 Apr; 112():108613. PubMed ID: 30784918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of RNA N6-methyladenosine modification in cancer progression.
    Chen B; Li Y; Song R; Xue C; Xu F
    Mol Biol Rep; 2019 Feb; 46(1):1383-1391. PubMed ID: 30788764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance.
    Paramasivam A; Priyadharsini JV
    Br J Cancer; 2021 May; 124(10):1621-1622. PubMed ID: 33723389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
    Liang Z; Kidwell RL; Deng H; Xie Q
    Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of RNA N6-methyladenosine modification in cancer progression.
    Chen B; Li Y; Song R; Xue C; Xu F
    Mol Biol Rep; 2019 Apr; 46(2):2567-2575. PubMed ID: 30911972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy.
    Xiang M; Liu W; Tian W; You A; Deng D
    Epigenomics; 2020 May; 12(9):801-809. PubMed ID: 32515221
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of RNA modification N6-methyladenosine in human cancer.
    Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
    Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into N6-methyladenosine and programmed cell death in cancer.
    Liu L; Li H; Hu D; Wang Y; Shao W; Zhong J; Yang S; Liu J; Zhang J
    Mol Cancer; 2022 Jan; 21(1):32. PubMed ID: 35090469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
    Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
    Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N
    Quan C; Belaydi O; Hu J; Li H; Yu A; Liu P; Yi Z; Qiu D; Ren W; Ma H; Gong G; Ou Z; Chen M; Sun Y; Chen J; Zu X
    Front Immunol; 2021; 12():697026. PubMed ID: 34526985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
    Qin S; Mao Y; Wang H; Duan Y; Zhao L
    Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
    Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
    J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Writers, readers, and erasers RNA modifications and drug resistance in cancer.
    Chen D; Gu X; Nurzat Y; Xu L; Li X; Wu L; Jiao H; Gao P; Zhu X; Yan D; Li S; Xue C
    Mol Cancer; 2024 Aug; 23(1):178. PubMed ID: 39215288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine links RNA metabolism to cancer progression.
    Dai D; Wang H; Zhu L; Jin H; Wang X
    Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects.
    Tang X; Guo M; Zhang Y; Lv J; Gu C; Yang Y
    J Exp Clin Cancer Res; 2024 Aug; 43(1):216. PubMed ID: 39095902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.